Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 6/20 | 0.42 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.36 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.36 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.36 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | SNCA | P37840 | 1/20 | 0.35 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | TDO2 | P48775 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31095221 | 0.87 | NFE2L2 (0.42) | NFE2L2NAPRTCYP11B2TRIM24TRIM33 | |
| SCHEMBL31095224 | 0.83 | HSD11B1 (0.43) | NFE2L2NAPRTTRIM24TRIM33RELA | |
| SCHEMBL31095207 | 0.83 | HSD11B1 (0.43) | NFE2L2NAPRTTRIM24TRIM33RELA | |
| SCHEMBL31095227 | 0.81 | CSNK1A1 (0.38) | NAPRTCYP11B2TRIM24TRIM33PDE10A | |
| SCHEMBL8486928 | 0.80 | NAPRT (0.48) | NFE2L2NAPRTTRIM24TRIM33AMY1A | |
| SCHEMBL8486922 | 0.80 | NAPRT (0.48) | NFE2L2NAPRTTRIM24TRIM33AMY1A | |
| SCHEMBL31095230 | 0.73 | NFE2L2 (0.47) | NFE2L2NAPRTTRIM24TRIM33 | |
| SCHEMBL31095185 | 0.70 | NFE2L2 (0.53) | NFE2L2NAPRTTRIM24TRIM33 | |
| SCHEMBL22001870 | 0.70 | F2RL1 (0.40) | NFE2L2RELAAMY1A | |
| SCHEMBL27707635 | 0.70 | F2RL1 (0.40) | NFE2L2RELAAMY1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680602-A1 | HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS | Miralinc Pharma, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024192237-A1 | HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS | MIRALINC PHARMA, INC. (US) | 2024-09-19 | — | — | WO | disclosed |